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WE DANCE ROUND IN A RING AND SUPPOSE, BUT 
THE SECRET SITS IN THE MIDDLE AND KNOWS. 
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• Androgen production is the primary function of 
testicular Leydig cells (1). Recently, Leydig cells of the 
human testis have been shown to possess, along with well 
developed smooth endoplasmic reticulum, cytoplasmic 
vesicles and storage granules similar to those found in 
neuroendocrine and nerve cells (2). Moreover, a series of 
nerve cell-specific substances has been detected in Leydig 
cells (reviewed in 3, 4). However, little is known about the 
physiological role of these molecules in testicular function. 
One of the neuroactive substances recently demonstrated in 
Leydig cells is C-type natriuretic peptide (CNP) (5). CNP (6) 
belongs to the family of natriuretic peptides, which also 
includes atrial natriuretic peptide (ANP), and brain natriuretic 
peptide (BNP). Whereas ANP and BNP are mainly secreted 
by cardiac cells to act as hormones in the regulation of blood 
pressure and fluid volume homeostasis (reviewed in 7), CNP is 
produced and is of particular physiological relevance in the 
brain (8-10). This peptide, which mediates its intracellular 
effects by the second messenger cyclic guanosine mono-
phosphate (cGMP), is an excellent molecule to investigate 
functional effects of neuroactive substances in the testis, 
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because cGMP is activated only by a small number of 
messenger molecules, namely the natriuretic peptides, nitric 
oxide (NO) and carbon monoxide (CO) (see 7). Therefore, the 
demonstration of components of the cGMP pathway permits to 
exclude effects of all other substances. 
The CNP receptor, designated as GC-B (11), represents a 
transmembrane protein containing an extracellular ligand-
binding domain, and an intracellular guanylate cyclase domain. 
Whereas CNP specifically binds to GC-B, the related receptor 
GC-A interacts with ANP and BNP (7). Ligand binding to 
these receptors results in activation of guanylate cyclase, 
leading to an intracellular accumulation of cGMP, which in 
turn regulates a variety of complex, not completely understood 
cellular functions (12). 
AUTOCRINE C-TYPE NATRIURETIC PEPTIDE 
EFFECTS IN LEYDIG   CELLS AND FUNCTIONALLY 
RELATED NEUROENDOCRINE CELLS 
• Autocrine effects are characterized by production of 
a substance and a receptor-mediated effect of this substance 
on the same cell (13). These criteria are fulfilled by Leydig 
cell CNP as it is produced and leads to a cGMP-mediated 
elevation of testosterone secretion in these cells (5, 14). 
Synthesis of CNP could not be detected in other testicular 
structures (5), suggesting that autocrine CNP effects on 
Leydig cells are characteristic for these particular cells. 
CNP is known to be associated with key neuroendocrine 
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structures (8, 10, 15). The highest density of CNP receptors 
was detected in the pineal and pituitary glands (16), while the 
highest CNP concentrations were found in the pituitary and 
hypothalamus (8). It is of special interest that in the pituitary 
CNP is exclusively produced by gonadotropes (17, 18), and 
that it exerts autocrine effects on these cells (17, 18) as well as 
on luteinizing hormone-releasing hormone (LHRH) neurons (19, 
20). This points to an importance of local CNP effects, 
especially on the neuroendocrine cells which centrally regulate 
Leydig cell function. Recently, in granulosa cells of the ovary, 
which had also been addressed a neuro endocrine organ (21), a 
local CNP system has been described (22). This suggests that 
CNP plays a crucial local role in the hormonal control of 
male and female reproduction. Taken together, the functionally 
related cells of the hypothalamic-pituitary-gonadal axis use, 
at least in part, the same autocrine mechanisms to modulate 
their function (Fig. 1), although the hormones produced by 
these cells are completely different, i.e. LHRH is a peptide, 
LH is a glycoprotein, and testosterone is a steroid. : 
Apart from CNP, NO is the only molecule also known to exert 
autocrine effects on LHRH neurons (19, 23), gonadotropes 
(24, 25), and Leydig cells (26, 27). We were able to 
demonstrate the presence of NO synthase (NOS) and NO 
receptor (soluble guanylate cyclase) by both 




Fig. 1. Autocrine effects of CNP in Leydig cells, gonadotropes, and LHRH neurons. In these cell types CNP is produced and 
leads to an accumulation of the second messenger cGMP mediated by guanylate cyclase B, the receptor for CNP (5,14,17-
20). Moreover, CNP induces an increase of testosterone release by Leydig cells (14), and an increase of LHRH secretion by 
LHRH neurons (20). 
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of cGMP in these cell types.  
Although ANP and BNP effects on Leydig cells, gonadotropes, 
and LHRH neurons have been described (14, 19, 24, 28), a 
local production of these natriuretic peptides remained 
undetectable in these cells (9, 29), suggesting the absence of 
autocrine actions. Probably, ANP and BNP effects on target 
cells are elicited by blood-derived ANP and BNP (30), while 
autocrine mechanisms in the gonadal axis cells are 
characteristic of CNP (and NO), but not of cGMP-
accumulating agents in general. Autocrine CNP effects 
have also been described in pinealocytes (31) and in adrenal 
gland zona glo-merulosa (32), indicating that the 
(neuro)endocrine CNP actions are not restricted to the 
gonadal axis, but are also present in other neuroendocrine 
and steroid-producing cells. Differences in the expression 
pattern of CNP among Leydig cells, gonadotropes, LHRH 
neurons, and pinealocytes, respectively (5,17,31), may 
indicate that only a subpopulation of these cell types synthesizes 
CNP. It is possible that CNP of a CNP-positive cell also may 
influence the neighbouring, perhaps CNP-negative, cells in a 
paracrine manner. 
PARACRINE C-TYPE NATRIURETIC PEPTIDE 
EFFECTS IN LEYDIG CELLS AND FUNCTIONALLY 
RELATED NEUROENDOCRINE CELLS 
• Leydig cells are close to the peritubular lamina 
propria (1, 33), and to testicular blood vessels (1, 34). Thus, 
Leydig cell-produced CNP may have direct influence on these 
structures. Since CNP has been found to act as a vasodilator 
(35, 36), mediating its effect via GC-B, cGMP, and apparently 
cGMP-dependent protein kinases (GK) (12), our finding of 
GC-B, cGMP, and GK I in testicular blood vessels as well as 
the observed CNP-mediated cGMP accumulation in these 
structures (37) strongly suggests a local vasorelaxant function 
(3 5). In both seminiferous tubules and tunica albuginea, CNP- 
induced cGMP (37) may mediate relaxation of myofibroblasts. 
Whereas endothelin, for example, has been shown to be 
involved in peritubular cell contraction in the rat (38), the 
agents responsible for relaxation have not yet been defined. 
Testicular myofibroblasts express filaments characteristic of 
fibroblasts and smooth muscle cells (33, 39). An influence of 
CNP on myofibroblasts may be postulated in the context of 
the well known effects of this factor on smooth muscle cells 
in other organs (36). In the testis, CNP may participate in the 
regulation of the peristaltic activity of the tubules by a direct 
influence on peritubular myofibroblasts or indirectly, by ef 
fects on myofibroblasts of tunica albuginea (Fig. 2). Tubular 
contractions in turn are necessary for sperm transport (40, 
41). Furthermore, CNP may influence the permeability of 
lamina propria, and thus the transport of nutrients into the 
tubular lumen (39). We were able to detect the components of 
cGMP pathways in pituitary, hypothalamic, and pineal blood 
vessels as well as to demonstrate a CNP-induced cGMP ac 
cumulation in isolated blood vessels of the bovine pineal 
gland.  
POTENTIAL FUNCTIONS OF C-TYPE NATRIURETIC 
PEPTIDE-IHDUCED cGMP IN HEUROEMDOCRIHE 
CELLS 
• As shown above, CNP has a dual function, exerting (i) 
autocrine effects on Leydig cells similar to other neuro 
endocrine cells, and (ii) paracrine effects on contractile cells 
(Fig. 2). Whereas paracrine cGMP-mediated effects on 
contractile cells result in relaxation, the primary function of 
CNP-induced cGMP accumulation in neuroendocrine cells 
remains obscure. In Leydig cells, a possible physiological 
involvement of CNP in androgen regulation has to be 
considered, since testosterone production constitutes the 
primary function of these cells. In fact, CNP has been shown 
to elevate testosterone release (14), but this effect was 
weaker compared to that of ANP or BNP (14). Thus, the endo- 
crinely acting ANP and BNP may be responsible for the 
modulation of testosterone release, whereas the locally acting 
CNP may affect other cellular functions. Accordingly, an 
influence of CNP on hormone secretion is absent, especially 
in the organs with the highest CNP concentration (pituitary), 
and the highest density of CNP receptors (pineal and pituitary) 
(17, 24, 31). 
Established actions of cGMP involve binding to either cyclic 
nucleotide-gated (CNG) ion channels, GK or cGMP-
dependent phosphodiesterases (reviewed in 12). Whereas 
direct effects of phosphodiesterases on testosterone production 
have been excluded (42), and CNG channels (43) as well as GK 
II (44) are not expressed in Leydig cells, the cytosolic GK I 
was detected in these cells by both immunoblotting and 
immunohistochemistry (37). However, stimulation of 
testosterone production by natriuretic peptides has been shown 
to result from a promiscuous activation of cAMP-dependent 
protein kinase by cGMP (42,45). The presence of GK I in this 
cell type strongly suggests that cGMP, accumulated in 
response to CNP, exerts further testosterone-independent actions. 
It is of particular interest that the expression levels of the 
components of the two cGMP-generating systems remain 
widely unchanged during each period of Leydig cell 
development (37), whereas the ability of these cells to produce 
testosterone dramatically changes (46). 
CNP, and therefore cGMP, has only a weak, if any, influence 
on hormone secretion by neuroendocrine cells. One possible 
CNP activity is to modulate the effects of the hormones or 
nerve fibers which primarily control cell function. In 
gonadotropes, for example, CNP decreases the LHRH 
effects on these cells (24). In the retina, it has been observed 
that the   
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Fig. 2. Schematic presentation of presumed testicular actions of CNP. CNP is produced in human Leydig cells. Based on the 
presence of specific receptors for CNP, Leydig cells, myofibroblasts of the tunica albuginea, myofibroblasts of the 
peritubular lamina propria and, vascular smooth muscle cells represent potential sites of CNP activity. This may result in 
relaxation of contractile cells, presumably mediated by cGMP and GKI (37). In Leydig cells, autocrine actions of CNP may 
influence testosterone production (14) via a promiscuous activation of' cAMP-dependent protein kinase by cGMP (42, 45). 
Additional hypothetical actions of CNP, possibly involved in the maintenance of normal Leydig cell phenotype by an 
interaction of cGMP with GK I (37), have to be considered. 
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function of gap junctions is regulated by cGMP. It is an 
attractive idea that a similar mechanism may also exist in 
neuroendocrine cells. Gap junctions between LHRH neurons or 
Leydig cells, which have recently been shown to be influenced 
by LH (47) might therefore synchronize hormone secretion 
of the cells in a cGMP-mediated manner. 
Our findings of a reduced expression of functionally active 
CNP receptors in both mouse (MA10) and human Leydig 
tumor cells (3 7) may focus on natriuretic peptides as antigrowth 
factors for a variety of cells, including mesangial, vascular 
endothelial, smooth muscle cells, and astrocytes (48). ANP 
receptors for example, are still present in Leydig tumor cells 
(17). Therefore, the decrease of CNP receptors can not be 
explained in the context of a general dedifferentiation. Since 
CNP production still persists in Leydig tumor cells, the 
interruption of autocrine CNP actions may be interpreted in 
the context of tumor development. Therefore, down -regulation of 
CNP receptors might prevent autocrine CNP action, possibly 
necessary for the maintenance of normal Leydig cell 
phenotype; a CNP-induced cGMP accumulation was also 
absent in Leydig tumor cells (37). Key factor of the postulated 
antigrowth effect of the CNP system in Leydig cells and other 
neuroendocrine cells might be the loss of fine modulation by 
CNP-induced cGMP. This raises the question whether cGMP-
binding proteins may act as transcription factors. In fact, GK I, 
which is present in Leydig and other neuroendocrine cells, has 
recently been shown to affect directly gene expression (49, 
50). Nevertheless, little is known about the series of events 
that underlie growth regulation by natriuretic peptides or 
cGMP. Signalling into the nucleus, characterization of nuclear 
targets, and influence on the cell cycle are the main aspects 
which have to be elucidated. 
CONCLUSION 
• With respect to the neuroendocrine properties of 
Leydig cells, the demonstration of CNP represents a further 
example for the production of neuroactive substances in these 
cells. Unlike the majority of substances previously detected 
in the testis, CNP has been shown to be functionally active, 
and to act via an autocrine mechanism in Leydig cells, like in 
well recognized neuroendocrine cells. Therefore, Leydig cells 
do not only resemble neuroendocrine cells by the substances 
produced, but also by their mechanism of activity. With 
respect to the presumed neuroectodermal origin of Leydig 
cells, it may be speculated that nerve cell-specific substances 
found in these cells may be ontogenetic relicts reflecting the 
origin of the cells, possibly without any functional sig 
nificance. The functionally active testicular CNP system, 
however, shows that neuroactive factors found in Leydig cells 
might play an essential physiological role. Also, the specific 
autocrine effects of CNP on the cells of the hypothalamic- 
pituitary-gonadal axis allow us to speculate that CNP agonists 
and antagonists could gain clinical interest to influence thera-
peutically reproductive function. Nevertheless, some 
questions remains to be resolved. For example, the 
mechanisms, by which CNP is produced and secreted in 
neuroendocrine cells and the essential function of CNP in 
neuroendocrine cells have not been elucidated. Investigations 
on the roles of CNP and NO systems have opened the door to an 
exciting, but hitherto neglected signal transduction pathway, 
the cGMP pathway. 
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